As necroptosis is an immunogenic form of cell death, we further evaluated whether CLL cells acquired characteristics associated with immunogenic cell death (ICD)55 upon treatment with the SHIP1 inhibitor 3AC. This evidence concerns the gene INPP5D and B-cell chronic lymphocytic leukemia.